NFE2L2 and Alzheimer disease: Compared with those in age-matched control individuals, the Nrf2 level in AD hippocampus was significantly reduced and restricted to the cytoplasm[20], and the activities of Nrf2-mediated SOD and glutathione peroxidase in AD tissues were reduced[21].